| Title {1} | Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a randomized, 2-parallel-group, evaluator blinded, superiority trial |
| Trial registration {2a and 2b}. | Clinicaltrials.gov registration: NCT03437772 (first posted: February 19, 2018). ClinicalTrials.Gov trial registry meets the WHO registry network criteria. WHO items are available at the registration link. |
| Protocol version {3} | Version 3.0 of this protocol was approved on 09/30/2019. Recruitment began on February 19th, 2018. |
| Funding {4} | Research grant by the French Government (“Programme Hospitalier de Recherche Clinique”) |
| Author details {5a} |
Laetitia Crouzet, MSc. a, Anne Gramond, MD, a, Carey Suehs, PhD, b, Pascale Fabbro-Peray, MD, PhD, b, Mocrane Abbar, MD, PhD, a, Jorge Lopez-Castroman, MD, PhD, a,c,d. a Department of Psychiatry, Nimes University Hospital, Nimes, France b Department of biostatistics, epidemiology, public health and medical information, Nimes University Hospital, Nimes, France c IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France d CIBERSAM, Spain |
| Name and contact information for the trial sponsor {5b} | Nimes University Hospital, Department of Clinical Research, Partnerships and Medical Projects, email: drc@chu-nimes.fr |
| Role of sponsor {5c} | Funder and sponsor had no involvement in the design, organization, analysis or preparation for publication of the study, and no authority over any of these activities. |